Latest Updates
-
Deepika Padukone Wears ₹90,000 Gold Kurta Set As Ranveer Singh, Daughter Dua Twin For Baby Devi’s Name Reveal -
Women, Menopause And Bone Health: Doctor Explains Why Osteoporosis Risk Rises After 40 -
Can Breast Cancer Be Detected Before Symptoms Appear? A Doctor Explains The Role Of Screening -
Papankusha Ekadashi 2026: October 21 Or 22? Know The Correct Date, Tithi And Significance -
OTT Releases This Week (October 19–25): New Movies And Series On Netflix, Prime Video, JioHotstar And Zee5 -
Police Commemoration Day 2026: Know The History, Significance And Programmes Planned Across India This Year -
Deepika Padukone And Ranveer Singh Announce Second Daughter’s Name On Dussehra, Share Family Photo -
Who Was Karthik Sabesh? Tamil Actor Passes Away At 37, Days After Uncle And Composer Deva’s Death -
Who Is Ravleen Varghese? Meet The First Malayali Model To Walk The Victoria’s Secret Runway -
World Osteoporosis Day 2026: A Minor Fall, A Major Fracture — Doctor On Why Older Adults Should Be Careful
Serum Institute Seeks Emergency Use Authorisation For Its rBCG Tuberculosis Vaccine
The Serum Institute has applied to the Drugs Controller General of India seeking emergency use authorisation for its recombinant BCG (rBCG) vaccine for the prevention of tuberculosis, official sources said on Sunday. The EUA application was submitted on March 22 by Prakash Kumar Singh, Director of Government and Regulatory Affairs at the Serum Institute of India (SII).

India's TB immunisation programme currently offers BCG vaccination at birth or as early as possible till one year of age.
SII already supplies life-saving vaccines to the government under the Universal Immunisation Programme, including Pneumococcal, IPV and Rotavirus, Singh mentioned in his letter.
The Pune-based firm is one of the companies which supply BCG vaccines to the government.
"Our government is committed to eliminating TB. The vision of TB-free India has been energised by the clarion call of the prime minister to end TB from our country by 2025, five years ahead of the Sustainable Development Goal of ending TB," Singh mentioned in his letter.
"Under the leadership of our CEO Adar C Poonawalla, our firm is committed to making available a safe, efficacious and high-quality world-class TUBERVAC-rBCG vaccine for newborns, children, adolescents and adults at an affordable price," an official source quoted Singh as having said in the application.
Recombinant BCG vaccines are manufactured through advanced technology that allows the insertion of foreign genes, or overexpression of native genes, into the BCG vaccine, an official explained.
The number of tuberculosis cases in India has seen a 19 per cent rise in 2021 over the previous year, and there has been an increase in the mortality rate due to all forms of TB between 2019 and 2020 by 11 per cent, according to the annual TB report released by Union Health Minister Mansukh Mandaviya on Thursday.
Disclaimer: The information provided in this article is for general informational and educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or a qualified healthcare provider with any questions you may have regarding a medical condition.



Click it and Unblock the Notifications
